Literature DB >> 10979152

Vitamin A and causes of maternal mortality: association and biological plausibility.

H Faisel1, R Pittrof.   

Abstract

OBJECTIVE: To review the association between major causes of maternal mortality and vitamin A, trying to determine if these associations are causal in nature, and to highlight possible biological pathways that may explain vitamin A effects.
DESIGN: Literature review, observational studies and clinical trials. The strength of association was determined by applying Bradford Hill criteria of causality.
RESULTS: In a vitamin A deficient population, vitamin A is essential for adequate treatment of anaemia. While vitamin A does not seem to be capable of preventing uterine atony, obstetric or surgical trauma, which are important causes of haemorrhage, it might be capable of preventing or decreasing coagulopathy. Possible effects on the placenta as regards implantation, site and size are not clear. As regards pregnancy-related infections, vitamin A supplementation can improve wound healing by decreasing fibrosis and increasing transforming growth factor-beta (TFG-beta). It can increase resistance to infection by increasing mucosal integrity, increasing surface immunoglobulin A (sIgA) and enhancing adequate neutrophil function. If infection occurs, vitamin A can act as an immune enhancer, increasing the adequacy of natural killer (NK) cells and increasing antibody production. beta-carotene in its provitamin form can act as an antioxidant by decreasing endothelial cell damage (the pathognomonic feature of pre-eclampsia) and promote the vasodilator effect of nitric oxide that might bring about a better outcome of toxaemia in pregnancy. It is unlikely that vitamin A or beta-carotene has an effect on obstructed labour.
CONCLUSIONS: Plausible biomedical pathways can only be constructed for obstetric haemorrhage, anaemia in pregnancy, hypertension in pregnancy and pregnancy-related infections. A 40% reduction in the maternal mortality ratio, as observed in Nepal, is unlikely to be solely explained through the aforementioned pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10979152     DOI: 10.1017/s1368980000000367

Source DB:  PubMed          Journal:  Public Health Nutr        ISSN: 1368-9800            Impact factor:   4.022


  5 in total

1.  Nutrition: vitamin A supplementation-maternal and neonatal survival.

Authors:  Parul Christian; Keith P West
Journal:  Nat Rev Endocrinol       Date:  2011-03-01       Impact factor: 43.330

2.  Effect of vitamin A supplementation on cause-specific mortality in women of reproductive age in Ghana: a secondary analysis from the ObaapaVitA trial.

Authors:  Lisa Hurt; Augustinus ten Asbroek; Seeba Amenga-Etego; Charles Zandoh; Samuel Danso; Karen Edmond; Chris Hurt; Charlotte Tawiah; Zelee Hill; Justin Fenty; Seth Owusu-Agyei; Oona M Campbell; Betty R Kirkwood
Journal:  Bull World Health Organ       Date:  2012-10-31       Impact factor: 9.408

3.  Gaps in the evidence for prevention and treatment of maternal anaemia: a review of systematic reviews.

Authors:  Jacqui A Parker; Filipa Barroso; Simon J Stanworth; Helen Spiby; Sally Hopewell; Carolyn J Doree; Mary J Renfrew; Shubha Allard
Journal:  BMC Pregnancy Childbirth       Date:  2012-06-24       Impact factor: 3.007

4.  Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.

Authors:  Hyon-Seung Yi; Hyuk Soo Eun; Young-Sun Lee; Ju Yeon Jung; Seol-Hee Park; Keun-Gyu Park; Hueng-Sik Choi; Jae Myoung Suh; Won-Il Jeong
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

5.  The development and evaluation of a community-based clinical diagnosis tool and treatment regimen for postpartum sepsis in Bangladesh and Pakistan.

Authors:  L A Bartlett; A E LeFevre; F Mir; S Soofi; S Arif; D K Mitra; M A Quaiyum; S Shakoor; M S Islam; N E Connor; P J Winch; M E Reller; R Shah; S El Arifeen; A H Baqui; Z A Bhutta; A Zaidi; S Saha; S A Ahmed
Journal:  Reprod Health       Date:  2016-02-25       Impact factor: 3.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.